Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
07/2008
07/02/2008EP1937650A1 Heterocyclic compounds
07/02/2008EP1730117A4 Thiourea compositions and uses thereof
07/02/2008CN101209996A Chemical synthesis method for 2-hydroxybenzimadazoles
07/02/2008CN100398539C Synthesis of heteroaryl acetamides
07/02/2008CN100398522C Inhibitors of cathepsin S
07/02/2008CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
06/2008
06/26/2008WO2008075196A1 Benzimidazole derivatives
06/26/2008WO2008074858A1 Intermediates and process for the production of 5-substituted tricyclic benzimidazoles
06/26/2008WO2008074795A1 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity
06/26/2008WO2008074578A2 Agent for dyeing fibers comprising keratin
06/26/2008WO2008074091A1 Radioprotector compounds and related methods
06/26/2008WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors
06/26/2008WO2006104755A3 Pretreatment compositions
06/26/2008CA2673417A1 Radioprotective benzimidazole compounds and related methods
06/26/2008CA2672957A1 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity
06/26/2008CA2672815A1 Benzimidazole derivatives for use in treating abnormal cell growth
06/25/2008EP1934187A1 Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
06/25/2008EP1934178A2 Substituted propylamine derivatives and methods of their use
06/25/2008EP1807398B1 New indole or benzimidazole derivatives
06/25/2008EP1748990B1 Process for the preparation of telmisartan
06/25/2008EP1697350B1 Tricyclic steroid hormone nuclear receptor modulators
06/25/2008CN101205214A Benzimidazole compounds for antiphlogistic and analgesic actions
06/25/2008CN100396675C Prodrugs of proton pump inhibitors
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/24/2008US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine
06/19/2008WO2008045371A3 N-substituted-azacyclylamines as histamine-3 antagonists
06/19/2008US20080146797 Process for synthesizing heterocyclic compounds
06/19/2008US20080146637 Benzimidazole trpv1 inhibitors
06/19/2008US20080146636 For therapy of obesity, hyperphagia, anxiety, depression and related disorders and diseases; cis-(S)-2-(1-{4-[(5-Bromo-indan-2-ylmethyl)-amino]-cyclohexyl}-5-chloro-1H-benzoimidazol-2-yl)-propan-2-ol
06/19/2008US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments
06/18/2008EP1931631A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
06/18/2008EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
06/18/2008EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use
06/18/2008CN101203522A Antineoplastic compounds and pharmaceutical compositions thereof
06/18/2008CN101203507A 2-substituted benzimidazoles
06/17/2008US7388099 Hydroxycucurbituril derivatives, their preparation methods and uses
06/12/2008WO2008036747A3 Composition and method for immunomodulation
06/12/2008WO2007089548A3 Compounds and methods for modulating protein trafficking
06/12/2008US20080139821 Disubstituted Cucurbiturils and Preparing Method Thereof
06/12/2008US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments
06/12/2008US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents
06/12/2008US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia
06/11/2008EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain
06/11/2008EP1509517B1 Novel synthesis of irbesartan
06/11/2008CN101198607A Phenylacetamides suitable as protein kinase inhibitors
06/11/2008CN101198594A Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
06/11/2008CN101195606A Method for synthesizing oxazoline ketone and cyclic urea compounds
06/11/2008CN101195605A Chemical synthesis method of 2-chlorin benzimidazole
06/11/2008CN101195589A Synthesis of temozolomide and analogs
06/11/2008CN100393700C Cathepsin cysteine protease inhibitors
06/10/2008US7385056 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem
06/10/2008US7384965 Fused heterocyclic derivatives as PPAR modulators
06/05/2008WO2008065754A1 Substituted carbinol compound
06/05/2008WO2008065021A1 Diaminocyclohexane and diaminocyclopentane derivatives
06/05/2008WO2008064830A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses
06/05/2008WO2008012782A3 Labelled analogues of halobenzamides as radiopharmaceuticals
06/05/2008WO2007013101A8 PROCESS FOR PRODUCING 2-(N-BUTYL)-3-[[2'-(TETRAZOL-5-YL)BIPHENYL- 4-YL]METHYL]-l,3-DIAZASPIRO[4.4] NON-1-EN-4-ONE
06/05/2008US20080132683 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis
06/05/2008US20080132550 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives; antiinflammatory agent, neurodegenerative diseases; inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease
06/05/2008US20080132539 e.g. 2-amino-5-[(naphthalen-1-ylmethyl)-aminocarbonyl]-pentanoic acid hydroxyamide; advanced glycosylation endproducts inhibitor; diabetic neurosis, diabetic retinopathy, atherosclerosis, cataract, Alzheimer's disease, rheumatic arthritis, osteoarthritis, chronic renal failure; food and cosmetics
06/05/2008US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides
06/05/2008US20080132459 Inhibitors of Histone Deacetylase
06/05/2008CA2670573A1 Diaminocyclohexane and diaminocyclopentane derivatives
06/04/2008EP1926714A1 Isotopically substituted benzimidazole derivatives
06/04/2008CN101193880A Exo- and diastereo- selective syntheses of himbacine analogs
06/04/2008CN101193869A Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/04/2008CN101193867A N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library
06/04/2008CN100391959C Pyrimidine-5-(1H)-ketone derivative
06/03/2008US7381825 Antiinflammatory agents; skin disorders; inflammatory bowel disorders
06/03/2008US7381737 5-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-ylmethyl]-thiophene-3-carboxylic acid; cell-cell and cell-substrate adhesion inhibitor; industrial scale; cyclization with condensed methylene precursor compound and glycine; separation of enantiomeric mixture
05/2008
05/29/2008WO2008061308A1 Protein tyrosine phosphatase modulators
05/29/2008WO2008008841A3 Use of benzimidazole derivatives for the treatment and/or prevention of autoimmune disorders
05/28/2008EP1776348B1 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
05/28/2008CN101189243A Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors
05/28/2008CN100390165C Medicinal composition containing alkyl acyl ramosqiong and its application
05/27/2008US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
05/22/2008WO2008059702A1 Process for purification of polycyclic compounds, process for production of polycyclic compounds, and uses of polycyclic compounds
05/22/2008WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
05/22/2008WO2008059026A1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
05/22/2008WO2007127010A9 Diarylthiohydantoin compounds
05/22/2008US20080119655 preparing biotin through intermediiate such as Di(imidazolidinylmethyl)disulfide compound; transformation of thiazole ring to imadazole ring with methyl mercaptan appendage
05/22/2008US20080119534 Benzimidazole Derivatives as Therapeutic Agents
05/22/2008US20080119522 5,6-dichloro-2-(2,2,2-trifluoro-ethyl)-1H-benzimidazole for example; use for prostate cancer, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive, and/or as a male performance enhancer
05/22/2008US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
05/22/2008US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes
05/22/2008US20080118774 Metal complexed with a multicyclo hetero ring; emission with a high luminance, high illuminant efficiency, low drive voltage, favorable color purity, high thermal steadiness
05/22/2008CA2669884A1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/20/2008US7375235 Viricides; such as 2-bromo-5,6-dichlorobenzimidazole; cyclizing 4,5-dichloro-o-phenylenediamine with carbonyl di-imidazole
05/20/2008US7375228 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion
05/20/2008US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators
05/20/2008CA2395717C Fused imidazolium derivatives
05/15/2008WO2008057775A2 Heterocyclic amide compounds useful as kinase inhibitors
05/15/2008WO2008057282A1 Calcium receptor modulating agents
05/15/2008WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008WO2007034254A8 Amino-alkyl-amide derivatives as ccr3 receptor ligands
05/15/2008CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/14/2008CN101180276A 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
05/14/2008CN100387597C Amide substituted imidazopyridines
05/13/2008US7371870 Benzimidazolone compound
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 154